Skip to content
GenoLensGenoLens

LTBP3

Chr 11q13.1

latent transforming growth factor beta binding protein 3

MANE:
ENST00000301873.11

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Amelogenesis imperfecta

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Thoracic aortic aneurysm or dissection (GMS)

    BIALLELIC, autosomal or pseudoautosomal
  • Bilateral congenital or childhood onset cataracts

  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • brachyolmia-amelogenesis imperfecta syndrome

    0.78
  • geleophysic dysplasia

    0.71
  • osteoarthritis, hip

    0.49
  • type 2 diabetes mellitus

    0.45
  • diabetes mellitus

    0.44
  • gout

    0.41
  • otosclerosis

    0.41
  • Acromicric dysplasia

    0.38
  • glaucoma

    0.34
  • adult onset asthma

    0.30

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Latent-transforming growth factor beta-binding protein 2

May play an integral structural role in elastic-fiber architectural organization and/or assembly

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.